Determination of midazolam and its major metabolite 1'-hydroxymidazolam by high-performance liquid chromatography-electrospray mass spectrometry in plasma from children.
We have developed a sensitive, selective and reproducible reversed-phase high-performance liquid chromatography method coupled with electrospray ionization mass spectrometry (HPLC-ESI-MS) for the simultaneous quantification of midazolam (MDZ) and its major metabolite, 1'-hydroxymidazolam (1...
Asıl Yazarlar: | Muchohi, SN, Ward, SA, Preston, L, Newton, C, Edwards, G, Kokwaro, G |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2005
|
Benzer Materyaller
-
Pharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsions.
Yazar:: Muchohi, SN, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Differential depression of neuronal network activity by midazolam and its main metabolite 1-hydroxymidazolam in cultured neocortical slices
Yazar:: Monika Balk, ve diğerleri
Baskı/Yayın Bilgisi: (2017-06-01) -
Pharmacokinetics and clinical efficacy of midazolam and lorazepam in Kenyan children with severe malaria and convulsions [MIM-MN-175440]
Yazar:: Muchohi, S, ve diğerleri
Baskı/Yayın Bilgisi: (2005) -
Determination of lorazepam in plasma from children by high-performance liquid chromatography with UV detection.
Yazar:: Muchohi, SN, ve diğerleri
Baskı/Yayın Bilgisi: (2005) -
Pharmacokinetics study of atracurium, dexmedetomidine, midazolam and 1-hydroxymidazolam in patients undergoing acute aortic dissection surgery
Yazar:: Huiling Si, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)